NF EN ISO 14155

NF EN ISO 14155

May 2012
Standard Cancelled

Clinical investigation of medical devices for human subjects - Good clinical practice

ISO 14155:2011 addresses good clinical practice for the design, conduct, recording and reporting of clinical investigations carried out in human subjects to assess the safety or performance of medical devices for regulatory purposes. The principles set forth in ISO 14155:2011 also apply to all other clinical investigations and should be followed as far as possible, depending on the nature of the clinical investigation and the requirements of national regulations. ISO 14155:2011 specifies general requirements intended to protect the rights, safety and well-being of human subjects, ensure the scientific conduct of the clinical investigation and the credibility of the results, define the responsibilities of the sponsor and principal investigator, and assist sponsors, investigators, ethics committees, regulatory authorities and other bodies involved in the conformity assessment of medical devices. ISO 14155:2011 does not apply to in vitro diagnostic medical devices.

View the extract
Main informations

Collections

National standards and national normative documents

Publication date

May 2012

Number of pages

73 p.

Reference

NF EN ISO 14155

ICS Codes

11.100.20   Biological evaluation of medical devices

Classification index

S99-201

Print number

1 - 16/04/2012

International kinship

European kinship

EN ISO 14155:2011
Sumary
Clinical investigation of medical devices for human subjects - Good clinical practice

ISO 14155:2011 addresses good clinical practice for the design, conduct, recording and reporting of clinical investigations carried out in human subjects to assess the safety or performance of medical devices for regulatory purposes.

The principles set forth in ISO 14155:2011 also apply to all other clinical investigations and should be followed as far as possible, depending on the nature of the clinical investigation and the requirements of national regulations.

ISO 14155:2011 specifies general requirements intended to protect the rights, safety and well-being of human subjects, ensure the scientific conduct of the clinical investigation and the credibility of the results, define the responsibilities of the sponsor and principal investigator, and assist sponsors, investigators, ethics committees, regulatory authorities and other bodies involved in the conformity assessment of medical devices.

ISO 14155:2011 does not apply to in vitro diagnostic medical devices.

Replaced standards (1)
NF EN ISO 14155
March 2011
Standard Cancelled
Clinical investigation of medical devices for human subjects - Good clinical practice

<p>ISO 14155:2011 addresses good clinical practice for the design, conduct, recording and reporting of clinical investigations carried out in human subjects to assess the safety or performance of medical devices for regulatory purposes. </p> <p>The principles set forth in ISO 14155:2011 also apply to all other clinical investigations and should be followed as far as possible, depending on the nature of the clinical investigation and the requirements of national regulations.</p> <p>ISO 14155:2011 specifies general requirements intended to protect the rights, safety and well-being of human subjects, ensure the scientific conduct of the clinical investigation and the credibility of the results, define the responsibilities of the sponsor and principal investigator, and assist sponsors, investigators, ethics committees, regulatory authorities and other bodies involved in the conformity assessment of medical devices.</p> <p>ISO 14155:2011 does not apply to <i>in vitro</i> diagnostic medical devices.</p>

Standard replaced by (1)
NF EN ISO 14155
August 2020
Standard Current
Clinical investigation of medical devices for human subjects - Good clinical practice

<p>This document addresses good clinical practice for the design, conduct, recording and reporting of clinical investigations carried out in human subjects to assess the clinical performance or effectiveness and safety of medical devices.</p> <p>For post-market clinical investigations, the principles set forth in this document are intended to be followed as far as relevant, considering the nature of the clinical investigation (see Annex I).</p> <p>This document specifies general requirements intended to</p> <p>— protect the rights, safety and well-being of human subjects,</p> <p>— ensure the scientific conduct of the clinical investigation and the credibility of the clinical investigation results,</p> <p>— define the responsibilities of the sponsor and principal investigator, and</p> <p>— assist sponsors, investigators, ethics committees, regulatory authorities and other bodies involved in the conformity assessment of medical devices.</p> <p>NOTE 1 Users of this document need to consider whether other standards and/or national requirements also apply to the investigational device(s) under consideration or the clinical investigation. If differences in requirements exist, the most stringent apply.</p> <p>NOTE 2 For Software as a Medical Device (SaMD) demonstration of the analytical validity (the SaMD's output is accurate for a given input), and where appropriate, the scientific validity (the SaMD's output is associated to the intended clinical condition/physiological state), and clinical performance (the SaMD's output yields a clinically meaningful association to the target use) of the SaMD, the requirements of this document apply as far as relevant (see Reference [4]). Justifications for exemptions from this document can consider the uniqueness of indirect contact between subjects and the SaMD.</p> <p>This document does not apply to <i>in vitro</i> diagnostic medical devices. However, there can be situations, dependent on the device and national or regional requirements, where users of this document might consider whether specific sections and/or requirements of this document could be applicable.</p>

Table of contents
View the extract
  • Avant-propos
    v
  • 1 Domaine d'application
    1
  • 2 Références normatives
    1
  • 3 Termes et définitions
    2
  • 4 Considérations éthiques
    8
  • 4.1 Généralités
    8
  • 4.2 Influence ou incitation abusives
    8
  • 4.3 Compensation et soins de santé supplémentaires
    8
  • 4.4 Responsabilités
    8
  • 4.5 Communication avec le comité d'éthique
    8
  • 4.6 Populations vulnérables
    10
  • 4.7 Consentement éclairé
    10
  • 5 Planification de l'investigation clinique
    14
  • 5.1 Généralités
    14
  • 5.2 Évaluation des risques
    14
  • 5.3 Justification de la conception de l'investigation clinique
    15
  • 5.4 Plan d'investigation clinique
    15
  • 5.5 Brochure de l'investigateur
    15
  • 5.6 Cahier d'observations
    16
  • 5.7 Plan de surveillance
    16
  • 5.8 Choix du site d'investigation
    16
  • 5.9 Accord(s)
    16
  • 5.10 Étiquetage
    16
  • 5.11 Comité de surveillance des données
    16
  • 6 Conduite d'une investigation clinique
    17
  • 6.1 Généralités
    17
  • 6.2 Initiation du site d'investigation
    17
  • 6.3 Surveillance du site d'investigation
    17
  • 6.4 Événements indésirables et défectuosités du dispositif
    17
  • 6.5 Documents de l'investigation clinique
    18
  • 6.6 Membres supplémentaires de l'équipe du site d'investigation
    18
  • 6.7 Respect de la vie privée du sujet et confidentialité des données
    18
  • 6.8 Maîtrise des documents et des données
    18
  • 6.9 Décompte des dispositifs sous investigation
    19
  • 6.10 Prise en compte des sujets
    20
  • 6.11 Audits
    20
  • 7 Suspension, arrêt et clôture de l'investigation clinique
    21
  • 7.1 Suspension ou arrêt prématuré de l'investigation clinique
    21
  • 7.2 Clôture de routine
    22
  • 7.3 Rapport d'investigation clinique
    23
  • 7.4 Conservation des documents
    23
  • 8 Responsabilités du promoteur
    24
  • 8.1 Assurance qualité et contrôle qualité cliniques
    24
  • 8.2 Planification et conduite de l'investigation clinique
    24
  • 8.3 Délégation externe des tâches et des fonctions
    30
  • 8.4 Communication avec les autorités réglementaires
    30
  • 9 Responsabilités de l'investigateur principal
    30
  • 9.1 Généralités
    30
  • 9.2 Qualifications de l'investigateur principal
    30
  • 9.3 Qualification du site d'investigation
    31
  • 9.4 Communication avec le comité d'éthique
    31
  • 9.5 Processus d'obtention du consentement éclairé
    31
  • 9.6 Conformité avec le plan d'investigation clinique
    31
  • 9.7 Soins médicaux des sujets
    32
  • 9.8 Rapport de sécurité
    33
  • Annexe A (normative) Plan d'investigation clinique
    34
  • Annexe B (normative) Brochure de l'investigateur
    41
  • Annexe C (informative) Cahier d'observations
    43
  • Annexe D (informative) Rapport d'investigation clinique
    45
  • Annexe E (informative) Documents essentiels de l'investigation clinique
    50
  • Annexe F (informative) Catégorisation des événements indésirables
    58
  • Bibliographie
    61
ZOOM ON ... the Requirements department
To comply with a standard, you need to quickly understand its issues in order to determine its impact on your activity.

The Requirements department helps you quickly locate within the normative text:
- mandatory clauses to satisfy,
- non-essential but useful clauses to know, such as permissions and recommendations.

The identification of these types of clauses is based on the document “ISO / IEC Directives, Part 2 - Principles and rules of structure and drafting of ISO documents ”as well as on a constantly enriched list of verbal forms.

With Requirements, quickly access the main part of the normative text!

With Requirements, quickly access the main part of the normative text!
Need to identify, monitor and decipher standards?

COBAZ is the simple and effective solution to meet the normative needs related to your activity, in France and abroad.

Available by subscription, CObaz is THE modular solution to compose according to your needs today and tomorrow. Quickly discover CObaz!

Request your free, no-obligation live demo

I discover COBAZ